Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Maja Ludvigsen

Aarhus University

Denmark

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Cell Biology

70%

Immunology

80%

Cancer Biology

60%

Immunohistochemistry

30%

Epithelial-mesenchymal Transition

30%

Lymphoma

30%

Hematology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo

Article Link

Year:

2023

IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients

Article Link

Year:

2023

Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients

Article Link

Year:

2022

Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups

Article Link

Year:

2022

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients

Article Link

Year:

2022

Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation

Article Link

Year:

2022

Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry

Article Link

Year:

2022

Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling

Article Link

Year:

2022

<i>IGHV</i>-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than <i>IGHV</i> mutation load.

Article Link

Year:

2021

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia

Article Link

Year:

2021

Collaborators21

Dianna Hussmann

Aarhus University

DENMARK

Peter Hokland

Aarhus University

DENMARK

Maja Andersen

Aarhus University

DENMARK

Rasmus Brøndum

Aalborg University

DENMARK

Carina Agerbo Rosenberg

Aarhus University

DENMARK

Iben Daugaard

Aarhus University

DENMARK

Rasmus Bak

Aarhus University

DENMARK

Anna Starnawska

Aarhus University

DENMARK

Boe Sorensen

Aarhus University

DENMARK

Michael Boe Møller

Syddansk Universitet Det Sundhedsvidenskabelige Fakultet

DENMARK

Martin B. Pedersen

Aarhus University

DENMARK

Marie Bill

Aarhus University

DENMARK

Yonglun Luo

DENMARK

Thomas Stauffer Larsen

Odense University Hospital

DENMARK

Mette Nyegaard

Aalborg University

DENMARK

Signe Neldeborg

Aarhus University

DENMARK

Anni Aggerholm

Aarhus University Hospital

DENMARK

Stephen Hamilton-Dutoit

Aarhus University

DENMARK

Ole Rahbek

Clinical Professor, Consultant

Aalborg University Hospital

DENMARK

Magnus Stougaard

Aarhus University

DENMARK

Bent Honoré

Aarhus University

DENMARK

How do I reach out?

Meet Kite AI